Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0089599Aexternal-prioritypatent/AT500670A1/en
Application filed by Bio & Bio Licensing SafiledCriticalBio & Bio Licensing Sa
Application grantedgrantedCritical
Publication of ATE263575T1publicationCriticalpatent/ATE263575T1/en
A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
A61K38/36—Blood coagulation or fibrinolysis factors
A61K38/363—Fibrinogen
Landscapes
Health & Medical Sciences
(AREA)
Life Sciences & Earth Sciences
(AREA)
Immunology
(AREA)
Medicinal Chemistry
(AREA)
Gastroenterology & Hepatology
(AREA)
Chemical & Material Sciences
(AREA)
Engineering & Computer Science
(AREA)
Bioinformatics & Cheminformatics
(AREA)
Hematology
(AREA)
Zoology
(AREA)
Pharmacology & Pharmacy
(AREA)
Proteomics, Peptides & Aminoacids
(AREA)
Epidemiology
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
AT00936524T1999-05-192000-05-19
MEDICINAL PRODUCT FOR TOPICAL USE CONTAINING FIBRINOGEN, THROMBIN, TRANSGLUTAMINASES AND PROTEINASE INHIBITORS
ATE263575T1
(en)